Federated Hermes’s Xeris Biopharma Holdings XERS Stock Holding History

Federated Hermes’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4M	Buy	1,434,433 +577,620	+67%	+$3.69M	0.02%	651
2026 Q1	$4.97M	Buy	856,813 +1,925	+0.2%	+$12.8K	0.01%	803
2025 Q4	$6.71M	Buy	854,888 +150,505	+21%	+$1.18M	0.01%	729
2025 Q3	$5.73M	Buy	704,383 +13,002	+2%	+$86.4K	0.01%	709
2025 Q2	$3.23M	Buy	691,381 +3,598	+0.5%	+$16.5K	0.01%	838
2025 Q1	$3.78M	Buy	687,783 +685,906	+36,543%	+$2.77M	0.01%	782
2024 Q4	$6.36K	Buy	1,877 +1,696	+937%	+$5.46K	﹤0.01%	1878
2024 Q3	$516	Buy	+181	New	+$465	﹤0.01%	2000
2023 Q3	–	Sell	-44,839	Closed	-$117K	–	2213
2023 Q2	$117K	Buy	+44,839	New	+$114K	﹤0.01%	1606
2021 Q2	–	Sell	-300,000	Closed	-$1.35M	–	2349
2021 Q1	$1.35M	Hold	300,000	–	–	﹤0.01%	1256
2020 Q4	$1.48M	Hold	300,000	–	–	﹤0.01%	1181
2020 Q3	$1.78M	Hold	300,000	–	–	﹤0.01%	1041
2020 Q2	$798K	Hold	300,000	–	–	﹤0.01%	1327
2020 Q1	$585K	Hold	300,000	–	–	﹤0.01%	1332
2019 Q4	$2.12M	Hold	300,000	–	–	﹤0.01%	1011
2019 Q3	$2.95M	Hold	300,000	–	–	0.01%	915
2019 Q2	$3.43M	Hold	300,000	–	–	0.01%	901
2019 Q1	$3.01M	Hold	300,000	–	–	0.01%	916
2018 Q4	$5.1M	Hold	300,000	–	–	0.01%	730
2018 Q3	$5.27M	Hold	300,000	–	–	0.01%	790
2018 Q2	$5.69M	Buy	+300,000	New	+$5.83M	0.02%	643

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Federated Hermes's XERS Position: Q2 2026 in Review

Federated Hermes increased its Xeris Biopharma Holdings (XERS) stake by 67% in Q2 2026, buying an estimated $3.69M and bringing the position to 1,434,433 shares worth $11.4M. The position accounts for 0.02% of the portfolio, ranked #651.

Federated Hermes first reported a position in XERS in Q2 2018 and has held it in 21 quarters since. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

Federated Hermes held 1,434,433 shares of Xeris Biopharma Holdings worth $11.4M as of Q2 2026.
Federated Hermes bought 577,620 Xeris Biopharma Holdings shares in Q2 2026, an estimated $3.69M.
Xeris Biopharma Holdings made up 0.02% of Federated Hermes's portfolio in Q2 2026, its #651 holding.
Federated Hermes first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 21 quarters since.
241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.